Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Laure Dupitout is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for kidney cancer, with a particular focus on robotic-assisted partial nephrectomy. Her major contributions lie in demonstrating the safety, efficacy, and oncologic outcomes of robotic surgery for complex renal tumors, as evidenced by her landmark multi-institutional study, "3D-Image guided robotic-assisted partial nephrectomy: a multi-institutional propensity score-matched analysis (UroCCR study 51)," which has garnered 73 citations. This work has helped establish 3D imaging guidance as a valuable tool for improving surgical precision and patient outcomes. Dr. Dupitout has also broken new ground in salvage surgery, as shown in her study "Feasibility of salvage robotic partial nephrectomy after ablative treatment failure (UroCCR-62 study)," which addresses a critical gap in the literature by exploring robotic approaches for patients who experience local relapse after ablative therapies—a challenging scenario traditionally managed with open surgery. Her research directly impacts clinical decision-making, offering patients less invasive options even in difficult salvage settings. Through her leadership in the UroCCR collaborative network, Dr. Dupitout continues to shape the future of urologic oncology, making her a key figure for students and researchers interested in robotic surgery and kidney cancer management.